A detailed history of Baystate Wealth Management LLC transactions in Harrow Health, Inc. stock. As of the latest transaction made, Baystate Wealth Management LLC holds 3,066 shares of HROW stock, worth $104,857. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,066
Previous 3,066 -0.0%
Holding current value
$104,857
Previous $44,000 22.73%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Sep 21, 2023

BUY
$17.37 - $28.08 $53,256 - $86,093
3,066 New
3,066 $58,000
Q2 2021

Jul 26, 2021

SELL
$6.68 - $11.07 $16,633 - $27,564
-2,490 Reduced 44.82%
3,066 $28,000
Q4 2020

Jan 15, 2021

SELL
$4.76 - $6.93 $10,376 - $15,107
-2,180 Reduced 28.18%
5,556 $38,000
Q2 2020

Jul 28, 2020

BUY
$3.61 - $6.47 $27,926 - $50,051
7,736 New
7,736 $40,000

Others Institutions Holding HROW

About HARROW HEALTH, INC.


  • Ticker HROW
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 27,070,000
  • Market Cap $926M
  • Description
  • Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...
More about HROW
Track This Portfolio

Track Baystate Wealth Management LLC Portfolio

Follow Baystate Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.